Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Delta
Carapachay, Buenos Aires, Argentinadeltabiotech.com.ar ↗
- Ownership
- Private
- Employees
- ~11
- Development stage
- Other
01
Overview
Delta Biotech SA is an active pharmaceutical ingredient (API) manufacturer specializing in prostaglandins and vitamin D derivatives (calcitriol, alfacalcidol, calcipotriol, latanoprost, travoprost). Based in Argentina with two manufacturing plants, it supplies commercial-stage APIs globally for drugs targeting conditions such as calcium metabolism disorders, osteoporosis, psoriasis, and glaucoma. While the Argentine entity is independent, a related former UK entity, Delta Biotechnology Ltd., was acquired by Novozymes A/S.
- Therapeutic areas
- DermatologyOphthalmologyEndocrinology
- Modalities
- Small moleculeBiologic
- Industry
- Contract Manufacturing Organization
02
Partnerships
Synergistic collaborations and bulk API supply partnerships, details not disclosed
Beyond the preview
Go deeper on Delta.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Delta.